MesoTV | NOW ENROLLING: Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

MesoTV Podcast: Conversations Impacting the Mesothelioma Community - A podcast by Mesothelioma Applied Research Foundation

We are joined by Dr. Aaron Mansfield of the Mayo Clinic to discuss a new, now enrolling, clinical trial for peritoneal mesothelioma that randomizes patients into two arms: an arm that receives chemotherapy + bevacizumab, and an arm that receives chemotherapy, bevacizumab and immunotherapy.